Company / Operating Income per Share
NewAmsterdam Pharma Co N.V. Operating Income per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.91
FY2025
5-year range
-$3.19 / -$0.19
FY2021-FY2025
Trend
-2.0%
vs FY2024
Sector context
#113 of 196
Health Care
What the data says
At $-1.91, NewAmsterdam Pharma Co N.V.'s operating income per share ranks #113 of 196 in the Health Care sector. Operating Income per Share has fluctuated over the past 5 years, ranging from $-3.19 in FY2021 to $-0.19 in FY2022.
Based on SEC 10-K filings.
-1.91 in FY2025.
Improved from $-2.23 to $-1.91 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#113 of 196 in Health CareTop 58% of 196This company -$1.91 Sector average -$46.00
▼
+95.9% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 2.0% year-over-year.
- Ranks #113 out of 196 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.91 | -2.0% |
| FY2024 | -$1.87 | +16.1% |
| FY2023 | -$2.23 | -1087.4% |
| FY2022 | -$0.19 | +94.1% |
| FY2021 | -$3.19 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026